How proteomics reveals potential biomarkers in brain diseases.

about

Use of proteomics for the identification of novel drug targets in brain diseases.Psychiatric research: psychoproteomics, degradomics and systems biology.Neuroproteomics Studies: Challenges and Updates.

P2860

Q36785927-EEDDB7FE-A4A9-420E-9741-72C8DF0C5C89 Q37157851-CE244EEF-C265-4A72-8BE0-E85233A34ABB Q47721773-996398B4-4052-4443-A671-D066D5326E11

P2860

How proteomics reveals potential biomarkers in brain diseases.

Item

http://www.wikidata.org/entity/Q36322155

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

How proteomics reveals potential biomarkers in brain diseases.

@ast

How proteomics reveals potential biomarkers in brain diseases.

@en

type

Item

label

How proteomics reveals potential biomarkers in brain diseases.

@ast

How proteomics reveals potential biomarkers in brain diseases.

@en

prefLabel

How proteomics reveals potential biomarkers in brain diseases.

@ast

How proteomics reveals potential biomarkers in brain diseases.

@en

P1476

How proteomics reveals potential biomarkers in brain diseases.

@en

P2093

Helmut E Meyer

http://www.w3.org/2001/XMLSchema#string

Katrin Marcus

http://www.w3.org/2001/XMLSchema#string

Michael Hamacher

http://www.w3.org/2001/XMLSchema#string

Oliver Schmidt

http://www.w3.org/2001/XMLSchema#string

Thomas Schulenborg

http://www.w3.org/2001/XMLSchema#string

P2860

BRPK, a novel protein kinase showing increased expression in mouse cancer cell lines with higher metastatic potential

DJ-1 has a role in antioxidative stress to prevent cell death

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

Hereditary early-onset Parkinson's disease caused by mutations in PINK1

Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36

Amyloid plaque core protein in Alzheimer disease and Down syndrome

IntAct: an open source molecular interaction database

Linking genome and proteome by mass spectrometry: large-scale identification of yeast proteins from two dimensional gels

Alpha-synuclein in Lewy bodies

Probability-based protein identification by searching sequence databases using mass spectrometry data

P304

901-913

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14789450.2.6.901

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2005-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16307519

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

How proteomics reveals potential biomarkers in brain diseases.

about

P2860

P2860

How proteomics reveals potential biomarkers in brain diseases.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921